Parkinson's disease (PD) is a degenerative neurological disease presenting with motor and non-motor signs and symptoms. Approximately 30–50% of the patients experience pain. There is no consensus regarding the mechanisms and classification of pain in PD.
EPDA - European Parkinson's Disease Association (Neurology) - Tue, 8 January 2013
The American Academy of Neurology has released new guidelines on the treatment of painful diabetic neuropathy, based on the revision of the available literature, concluding that an only drug – pregabalin – can be defined as belonging to the “A” class, even if the studies on this product have shown only a modest advantage compared to placebo, with an efficacy entity of 10%-15%.
MedNews (Neurology) - Mon, 7 January 2013
Computed tomography of the head revealed a circumferential midbrain lesion with mass effect and hydrocephalus. Magnetic resonance imaging (MRI) and magnetic resonance angiography revealed an aneurysm (3.5 cm by 4 cm) at the bifurcation of the basilar artery, with compression of the midbrain and probably the mamillary body; these findings were confirmed by cerebral angiography.
New England Journal of Medicine (Neurology) - Tue, 13 November 2012
An inexpensive, five-minute eye scan can accurately assess the amount of brain damage in people with the debilitating autoimmune disorder multiple sclerosis (MS), and offer clues about how quickly the disease is progressing, according to results of two Johns Hopkins studies.
Johns Hopkins Hospital (Neurology) - Tue, 23 October 2012
Personalized treatment is highly desirable in Multiple Sclerosis (MS) because it is an immensely heterogeneous disease. This heterogeneity is seen in both the disease course and the treatment responses. Currently, a combination of clinical features and imaging parameters in MRI is used to classify active/non-active patients and treatment responders/non-responders. A review summarizes latest knowledge on this.
BioMed Central (Neurology) - Mon, 8 October 2012
Discovering the best way to help those with dementia deal with their condition is still in its early stages, but some research suggests that reminiscing about times-gone-by could make a difference.
BBC News (Neurology) - Tue, 3 July 2012
In a new study published in the scientific journal Neurology, scientists at Karolinska Institutet show that smaller forms of amyloid known as oligomers may be significant in the development of Alzheimer's disease - and are therefore a possible target for future drugs. These new findings add another piece to the puzzle of the complex dementia disease that affects so many people.
Karolinska Institutet (Neurology) - Tue, 19 June 2012
In the RE-LY study, on patients affected by atrial fibrillation and with a stroke risk, the administration of dabigatran (an oral inhibitor of thrombin) has reduced the risk of stroke and has presented a bleeding risk superimposable to the ones of warfarin.
MedNews (Neurology) - Mon, 14 May 2012
One of the questions with no answer is the one relative to survival in patients with an advanced stage of dementia, and the answer to this question often influences the decisions of possible hospitalizations in palliative care structures. With a prospective study, the prevision of death among 606 patients hospitalized in a protected structure in Massachusetts have been examined, according to two parameters: the ADEPT (Advanced Dementia Prognostic Tool) score, an evaluation scale including 12 factors, among which age, presence of trophic ulcers, incontinence, recent weight loss, where the scale ranges from 1 to 32.5 points and where the highest score indicates a lower survival.
MedNews (Neurology) - Wed, 2 May 2012
Researchers have analyzed past studies to investigate possible associations between maternal age and autism spectrum disorder. While much research has been done to identify potential genetic causes of autism, the current analysis suggests that non-heritable and environmental factors may also play a role in children's risk for autism.
Karolinska Institutet (Neurology) - Wed, 2 May 2012